ClearPoint Neuro, Inc. (CLPT)
USD 11.31
(-6.8%)
USD 11.31
(-6.8%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -22.08 Million USD | -33.57% |
| 2022 | -16.53 Million USD | -7.95% |
| 2021 | -15.32 Million USD | -68.2% |
| 2020 | -9.1 Million USD | -40.04% |
| 2019 | -6.5 Million USD | -5.53% |
| 2018 | -6.16 Million USD | 14.01% |
| 2017 | -7.16 Million USD | 11.18% |
| 2016 | -8.06 Million USD | 4.49% |
| 2015 | -8.44 Million USD | -86.73% |
| 2014 | -4.52 Million USD | 36.15% |
| 2013 | -7.08 Million USD | -24.17% |
| 2012 | -5.7 Million USD | 31.33% |
| 2011 | -8.31 Million USD | 12.09% |
| 2010 | -9.45 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -4.4 Million USD | -6.32% |
| 2024 Q1 | -4.14 Million USD | 10.24% |
| 2023 Q4 | -4.61 Million USD | 3.95% |
| 2023 Q1 | -5.39 Million USD | -25.37% |
| 2023 Q3 | -4.8 Million USD | 31.81% |
| 2023 Q2 | -7.05 Million USD | -30.79% |
| 2023 FY | -22.08 Million USD | -33.57% |
| 2022 Q3 | -3.78 Million USD | 14.11% |
| 2022 Q4 | -4.3 Million USD | -13.75% |
| 2022 Q1 | -4.05 Million USD | 2.29% |
| 2022 Q2 | -4.4 Million USD | -8.58% |
| 2022 FY | -16.53 Million USD | -7.95% |
| 2021 Q2 | -3.74 Million USD | -47.48% |
| 2021 FY | -15.32 Million USD | -68.2% |
| 2021 Q4 | -4.14 Million USD | -4.25% |
| 2021 Q1 | -2.53 Million USD | -60.43% |
| 2021 Q3 | -3.98 Million USD | -6.33% |
| 2020 Q2 | -1.66 Million USD | 19.16% |
| 2020 Q1 | -2.05 Million USD | -24.86% |
| 2020 Q4 | -1.58 Million USD | -6.59% |
| 2020 Q3 | -1.48 Million USD | 10.64% |
| 2020 FY | -9.1 Million USD | -40.04% |
| 2019 Q3 | -1.12 Million USD | 27.57% |
| 2019 Q4 | -1.64 Million USD | -46.55% |
| 2019 FY | -6.5 Million USD | -5.53% |
| 2019 Q1 | -1.22 Million USD | -0.23% |
| 2019 Q2 | -1.55 Million USD | -27.01% |
| 2018 Q2 | -1.87 Million USD | -14.36% |
| 2018 FY | -6.16 Million USD | 14.01% |
| 2018 Q4 | -1.21 Million USD | 14.71% |
| 2018 Q1 | -1.64 Million USD | 21.17% |
| 2018 Q3 | -1.42 Million USD | 23.9% |
| 2017 Q3 | -1.42 Million USD | 28.88% |
| 2017 FY | -7.16 Million USD | 11.18% |
| 2017 Q1 | -1.65 Million USD | 1.5% |
| 2017 Q2 | -2 Million USD | -21.06% |
| 2017 Q4 | -2.08 Million USD | -46.03% |
| 2016 Q3 | -2.56 Million USD | -43.84% |
| 2016 Q2 | -1.78 Million USD | 12.81% |
| 2016 Q1 | -2.04 Million USD | -70.54% |
| 2016 FY | -8.06 Million USD | 4.49% |
| 2016 Q4 | -1.68 Million USD | 34.42% |
| 2015 FY | -8.44 Million USD | -86.73% |
| 2015 Q4 | -1.19 Million USD | -388.36% |
| 2015 Q3 | -245.39 Thousand USD | 91.98% |
| 2015 Q2 | -3.06 Million USD | 22.43% |
| 2015 Q1 | -3.94 Million USD | -106.04% |
| 2014 Q3 | -3.64 Million USD | -128.94% |
| 2014 Q1 | 2.63 Million USD | 253.31% |
| 2014 Q4 | -1.91 Million USD | 47.5% |
| 2014 FY | -4.52 Million USD | 36.15% |
| 2014 Q2 | -1.59 Million USD | -160.56% |
| 2013 Q4 | -1.71 Million USD | 46.29% |
| 2013 FY | -7.08 Million USD | -24.17% |
| 2013 Q1 | -950 Thousand USD | -70.19% |
| 2013 Q2 | -1.35 Million USD | -42.31% |
| 2013 Q3 | -3.19 Million USD | -136.31% |
| 2012 Q4 | -558.21 Thousand USD | 48.05% |
| 2012 Q2 | -599.97 Thousand USD | 82.73% |
| 2012 Q1 | -3.47 Million USD | -87.21% |
| 2012 FY | -5.7 Million USD | 31.33% |
| 2012 Q3 | -1.07 Million USD | -79.1% |
| 2011 FY | -8.31 Million USD | 12.09% |
| 2011 Q3 | -2.13 Million USD | -3.21% |
| 2011 Q4 | -1.85 Million USD | 13.1% |
| 2011 Q2 | -2.06 Million USD | 0.0% |
| 2010 FY | -9.45 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 64.152% |
| BrainsWay Ltd. | -4.19 Million USD | -426.305% |
| Cerus Corporation | -37.48 Million USD | 41.079% |
| Envoy Medical, Inc. | -29.9 Million USD | 26.144% |
| electroCore, Inc. | -18.83 Million USD | -17.283% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -149.593% |
| IceCure Medical Ltd | -14.65 Million USD | -50.758% |
| Inogen, Inc. | -102.44 Million USD | 78.439% |
| OrthoPediatrics Corp. | -20.97 Million USD | -5.316% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 58.058% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -60.703% |
| MaxCyte, Inc. | -37.92 Million USD | 41.753% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -86.256% |
| Nexalin Technology, Inc. | -4.64 Million USD | -375.164% |
| Orthofix Medical Inc. | -151.39 Million USD | 85.41% |
| PAVmed Inc | -64.17 Million USD | 65.58% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 57.899% |
| RxSight, Inc. | -48.6 Million USD | 54.557% |
| Sight Sciences, Inc. | -55.54 Million USD | 60.234% |
| SI-BONE, Inc. | -43.33 Million USD | 49.029% |
| TELA Bio, Inc. | -46.66 Million USD | 52.664% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 55.4% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -62.622% |
| Acutus Medical, Inc. | -81.66 Million USD | 72.951% |
| Talis Biomedical Corporation | -62 Million USD | 64.377% |
| Spectral AI, Inc. | -20.85 Million USD | -5.922% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 63.655% |
| CVRx, Inc. | -41.19 Million USD | 46.385% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 3550.35% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -101.629% |
| Bioventus Inc. | -156.23 Million USD | 85.861% |
| Venus Concept Inc. | -37.25 Million USD | 40.701% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 62.585% |
| LivaNova PLC | 17.54 Million USD | 225.892% |
| 908 Devices Inc. | -36.39 Million USD | 39.314% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 88.165% |
| Nemaura Medical Inc. | -14.14 Million USD | -56.175% |
| NeuroPace, Inc. | -32.95 Million USD | 32.974% |
| LENSAR, Inc. | -14.38 Million USD | -53.577% |
| Apyx Medical Corporation | -18.71 Million USD | -18.041% |
| Cutera, Inc. | -162.83 Million USD | 86.435% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -103.961% |
| BioSig Technologies, Inc. | -29.04 Million USD | 23.939% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 73.28% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 132.608% |
| Axonics, Inc. | -6.08 Million USD | -262.829% |
| Outset Medical, Inc. | -172.79 Million USD | 87.217% |
| IRIDEX Corporation | -9.57 Million USD | -130.815% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 79.141% |
| IRadimed Corporation | 17.19 Million USD | 228.478% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -167.94% |
| INVO Bioscience, Inc. | -8.03 Million USD | -174.923% |
| Telesis Bio, Inc. | -47.72 Million USD | 53.715% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 315.65% |
| Varex Imaging Corporation | -47.7 Million USD | 53.692% |
| Quipt Home Medical Corp. | -2.78 Million USD | -693.427% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -95.72% |
| Pulmonx Corporation | -60.84 Million USD | 63.695% |
| Dynatronics Corporation | -2.69 Million USD | -718.803% |
| Modular Medical, Inc. | -17.47 Million USD | -26.44% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -93.984% |
| Semler Scientific, Inc. | 20.58 Million USD | 207.317% |
| InMode Ltd. | 197.91 Million USD | 111.161% |
| Bruker Corporation | 427.2 Million USD | 105.171% |
| Cytosorbents Corporation | -28.5 Million USD | 22.515% |
| DexCom, Inc. | 541.5 Million USD | 104.079% |
| Align Technology, Inc. | 445.05 Million USD | 104.963% |
| Viveve Medical, Inc. | -22.02 Million USD | -0.281% |
| ZimVie Inc. | -393.28 Million USD | 94.383% |
| Movano Inc. | -29.28 Million USD | 24.567% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -81.832% |
| Nexalin Technology, Inc. | -4.64 Million USD | -375.164% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 3550.35% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 90.077% |
| Profound Medical Corp. | -28.56 Million USD | 22.682% |
| Insulet Corporation | 206.3 Million USD | 110.707% |
| enVVeno Medical Corporation | -23.51 Million USD | 6.068% |
| Surmodics, Inc. | -11.54 Million USD | -91.379% |
| iCAD, Inc. | -4.84 Million USD | -355.725% |
| Nuwellis, Inc. | -20.2 Million USD | -9.303% |
| Biotricity, Inc. | -14.09 Million USD | -56.723% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 82.101% |
| Aethlon Medical, Inc. | -12.2 Million USD | -80.936% |
| InspireMD, Inc. | -19.91 Million USD | -10.911% |
| PAVmed Inc. | -64.17 Million USD | 65.58% |
| BIOLASE, Inc. | -20.63 Million USD | -7.062% |
| Beyond Air, Inc. | -60.24 Million USD | 63.333% |
| FONAR Corporation | 10.56 Million USD | 309.03% |
| AxoGen, Inc. | -21.71 Million USD | -1.718% |
| Vivani Medical, Inc. | -25.65 Million USD | 13.89% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 177.464% |
| Inari Medical, Inc. | -1.63 Million USD | -1250.183% |
| UFP Technologies, Inc. | 44.92 Million USD | 149.17% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -330.389% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -234.418% |
| Tenon Medical, Inc. | -15.58 Million USD | -41.769% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -43.193% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 37.483% |
| AdaptHealth Corp. | -678.89 Million USD | 96.746% |
| Sintx Technologies, Inc. | -8.25 Million USD | -167.454% |
| NanoVibronix, Inc. | -3.71 Million USD | -495.23% |
| Quanterix Corporation | -32.33 Million USD | 31.685% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -95.72% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 4654.433% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 92.799% |
| TransMedics Group, Inc. | -25.02 Million USD | 11.743% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 0.199% |
| NeuroMetrix, Inc. | -6.52 Million USD | -238.296% |
| Hyperfine, Inc. | -44.23 Million USD | 50.068% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 71.862% |
| Biomerica, Inc. | -5.97 Million USD | -269.505% |
| Bone Biologics Corporation | -8.94 Million USD | -146.839% |
| AVITA Medical, Inc. | -39.16 Million USD | 43.605% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -121.913% |
| Silk Road Medical, Inc | -55.74 Million USD | 60.373% |